Skip to content

Bexident Aftas Spray

by Bmg Pharma SpA EUDAMED

Active European Union

Ref 8052879051074

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number805287905BMG0723CL Basic UDI-DIDate29 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • EPT 0477.MDR.25/5968 Active

    Quality management system EU MDR

    Notified body
    0477
    Issued
    31 Oct 2025
    Expires
    5 Feb 2030

Specification

EUDAMED

Device Name
BMG0723
Model / Reference
8052879051074
Primary DI / UDI-DI
08052879051074
Basic UDI-DI
805287905BMG0723CL
EMDN Code
M9002 Protective devices, lubricants and soothing devices (sprays, gels, fluids and creams)
Device Class
Class IIa
Market of Registration
Portugal

Manufacturer details

EUDAMED SRN
IT-MF-000022509

Other devices from Bmg Pharma SpA

See all devices from Bmg Pharma SpA →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No